Organization · Venture Capital
Brooks Hill Partners
Brooks Hill Partners is a seed-stage venture capital firm based in Waltham, Massachusetts, focusing on investments at the intersection of healthcare and technology. They provide strategic consulting alongside capital to enhance growth for their portfolio companies.
Overview
What Brooks Hill Partners does
What Brooks Hill Partners is
Brooks Hill Partners is a seed-stage venture capital firm based in Waltham, Massachusetts, focusing on investments at the intersection of healthcare and technology. They provide strategic consulting alongside capital to enhance growth for their portfolio companies.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Founded
- Founded in 2016
- Approximate age
- About 10 years
- Structured capabilities
- Funder
- Last reviewed
- April 10, 2026
Official channels
Find Brooks Hill Partners elsewhere
Open the official website or a supported primary organization account.
Capability profile
Brooks Hill Partners as a funder
Investment thesis
Hybrid strategy consulting + seed-stage investment firm focused exclusively on the intersection of healthcare and technology (life sciences + health tech). Advisory work informs investment strategy and vice versa — a flywheel model where consulting clients become deal flow.
Focus narrative
Brooks Hill Partners invests in life sciences and health tech companies, offering customized solutions tailored to the specific needs of its clients and portfolio companies. The firm leverages data-driven strategies to enhance organizational capabilities and capitalize on market opportunities.
Value beyond capital
Brooks Hill Partners adds value to its portfolio companies by providing critical support during various stages of development, leveraging its expertise in healthcare and technology to enhance operational capabilities and market positioning.
Focus and fit
- Stages
- Seed
- Regions
- North America
Availability
- Currently deploying
- Not published
Portfolio and track record
- Recorded portfolio count
- 12
Portfolio context
Notable portfolio companies include: 3Derm - A skin imaging system for primary care physicians; Astrocyte Pharmaceuticals - Focused on neuroprotective drug development; Cake - A digital health platform for end-of-life planning; Calibrater Health - Intelligent process automation for healthcare; Cellbricks - 3D bioprinting for pharmaceutical research; DEEP 6 AI - AI for faster patient recruitment in clinical trials; Macula - AI-driven clinical microscopy; ProCredEx - Blockchain for healthcare credential validation; QULAB - AI and quantum computing for drug design; Reflect - Modern therapy solutions; Totient - ML for monoclonal antibody selection; Wasabi - High-capacity data archiving services.
Common questions
What to know about Brooks Hill Partners
Upseed classifies Brooks Hill Partners under the Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
April 10, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.